ALBANY, N.Y.--(BUSINESS WIRE)--Albany Molecular Research, Inc. (NASDAQ: AMRI) has completed its acquisition of two pharmaceutical manufacturing sites, along with additional land for expansion, in Aurangabad and Navi Mumbai, India for approximately $11 million in cash.
